{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:17:11Z","timestamp":1788797831372,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd011747","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000}}],"reference-count":89,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011747.pub2","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T17:45:12Z","timestamp":1486575912000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ranolazine for stable angina pectoris"],"prefix":"10.1002","volume":"2019","author":[{"given":"Carlos A","family":"Salazar","sequence":"first","affiliation":[{"name":"Universidad Peruana Cayetano Heredia; Department of Medicine; Avenida Honorio Delgado 430 San Martin de Porres Lima Lima Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan E","family":"Basilio Flores","sequence":"additional","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos; Faculty of Medicine; Av. Grau 755 Lima Lima Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz E","family":"Veramendi Espinoza","sequence":"additional","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos; Faculty of Medicine; Av. Grau 755 Lima Lima Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhon W","family":"Mejia Dolores","sequence":"additional","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos; Faculty of Medicine; Av. Grau 755 Lima Lima Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego E","family":"Rey Rodriguez","sequence":"additional","affiliation":[{"name":"Universidad Nacional Mayor de San Marcos; Faculty of Medicine; Av. Grau 755 Lima Lima Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Loza Mun\u00e1rriz","sequence":"additional","affiliation":[{"name":"Universidad Peruana Cayetano Heredia; Department of Nephrology; Hospital Cayetano Heredia Honorio Delgado 420 Lima Peru 31"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,2,8]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0001|cit1","first-page":"237","article-title":"Effects of ranolazine on left ventricular diastolic and systolic function in patients with chronic coronary disease and stable angina","volume":"56","author":"Babalis","year":"2015","journal-title":"Hellenic Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD011747.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD011747.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jcmg.2011.03.007","article-title":"Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease","volume":"4","author":"Mehta","year":"2011","journal-title":"JACC. Cardiovascular Imaging"},{"issue":"17","key":"10.1002\/14651858.CD011747.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial","volume":"53","author":"Wilson","year":"2009","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ahj.2012.03.018","article-title":"A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention","volume":"163","author":"Pelliccia","year":"2012","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(99)00190-3","article-title":"A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents","volume":"84","author":"Pepine","year":"1999","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjcard.2004.09.025","article-title":"Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris","volume":"95","author":"Rousseau","year":"2005","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.115.019768","article-title":"Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial","volume":"133","author":"Alexander","year":"2016","journal-title":"Circulation"},{"issue":"10014","key":"10.1002\/14651858.CD011747.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(15)00459-6","article-title":"Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Weisz","year":"2016","journal-title":"Lancet"},{"issue":"19","key":"10.1002\/14651858.CD011747.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0013|cit13","first-page":"OC01\u2013OC05","article-title":"Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease \u2013 a randomized controlled trial","volume":"9","author":"Sandhiya","year":"2015","journal-title":"Journal of Clinical and Diagnostic Research"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/TCRM.S82288","article-title":"Ranolazine versus placebo in patients with ischemic cardiomyopathy and persistent chest pain or dyspnea despite optimal medical and revascularization therapy: randomized, double-blind crossover pilot study","volume":"11","author":"Shammas","year":"2015","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/echo.12674","article-title":"Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Echocardiography"},{"issue":"20","key":"10.1002\/14651858.CD011747.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","article-title":"Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)","volume":"61","author":"Kosiborod","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD011747.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/01.CIR.90.2.726","article-title":"Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris","volume":"90","author":"Thadani","year":"1994","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","article-title":"Effects of ivabradine and ranolazine in patients with microvascular angina pectoris","volume":"112","author":"Villano","year":"2013","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD011747.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jamainternmed.2014.2120","article-title":"Effects of ranolazine on quality of life among patients with diabetes mellitus and stable angina","volume":"174","author":"Arnold","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0020|cit20","first-page":"131","article-title":"Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem","volume":"20","author":"Cocco","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD011747.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"e008861","DOI":"10.1136\/bmjopen-2015-008861","article-title":"Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective","volume":"5","author":"Coleman","year":"2015","journal-title":"BMJ Open"},{"issue":"9","key":"10.1002\/14651858.CD011747.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10198-013-0534-8","article-title":"Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain","volume":"15","author":"Hidalgo-Vega","year":"2014","journal-title":"European Journal of Health Economics"},{"issue":"2","key":"10.1002\/14651858.CD011747.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"111\u20134","DOI":"10.1007\/BF00265967","article-title":"Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium","volume":"38","author":"Jain","year":"1990","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD011747.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjcard.2014.01.407","article-title":"Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris","volume":"113","author":"Kohn","year":"2014","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD011747.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF03320519","article-title":"Economic evaluation of add-on ranolazine in the treatment of chronic stable angina","volume":"11","author":"Lucioni","year":"2009","journal-title":"Pharmacoeconomics Italian Research Articles"},{"issue":"8","key":"10.1002\/14651858.CD011747.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/MCA.0000000000000272","article-title":"Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease","volume":"26","author":"Rehberger-Likozar","year":"2015","journal-title":"Coronary Artery Disease"},{"issue":"4","key":"10.1002\/14651858.CD011747.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1076-7460.2007.07119.x","article-title":"Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris","volume":"16","author":"Rich","year":"2007","journal-title":"American Journal of Geriatric Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD011747.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jacc.2006.10.067","article-title":"Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE)","volume":"49","author":"Koren","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0029|cit29","unstructured":"NCT01304095 Ranolazine, ethnicity and the metabolic syndrome (REMS) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01304095?term=NCT01304095&rank=1"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/157016111106140128123506","article-title":"Effect of ranolazine in preventing postoperative atrial fibrillation in patients undergoing coronary revascularization surgery","volume":"11","author":"Tagarakis","year":"2013","journal-title":"Current Vascular Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD011747.pub2-BIB0031|cit31","first-page":"122","article-title":"Effect of ranolazine and diltiazem on patients with stable angina pectoris","volume":"50","author":"Tian","year":"2012","journal-title":"\u4e2d\u56fd\u73b0\u4ee3\u533b\u751f (Chinese Modern Physician)"},{"issue":"26","key":"10.1002\/14651858.CD011747.pub2-BIB0032|cit32","first-page":"2455","article-title":"Clinical observation of ranolazine hydrochloride sustained-release tablets in the treatment of stable angina pectoris","volume":"23","author":"Wang","year":"2012","journal-title":"\u4e2d\u56fd\u836f\u623f (Chinese Pharmacy)"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Calcagno S Taccheri T Carnesale R Nicol S Lembo M Bruno P Complete coronary revascularization in different clinical settings is not enough: role of ranolazine Journal of the American College of Cardiology 2014 12 S","DOI":"10.1016\/S0735-1097(14)61599-0"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0034|cit34","doi-asserted-by":"crossref","unstructured":"Calcagno S Severino P Taccheri T Placentino F Ceccacci A Cinque A Complete coronary revascularization in some clinical settings is not enough: comparison of ivabradine, ranolazine and standard medical therapy in term of efficacy and tolerability Journal of the American College of Cardiology 2015 10 S","DOI":"10.1016\/S0735-1097(15)61668-0"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0035|cit35","unstructured":"CTRI\/2014\/01\/004332 Effect of ranolazine on improvement of heart function http:\/\/ctri.nic.in\/Clinicaltrials\/showallp.php?mid1=7785&EncHid=&userName=CTRI\/2014\/01\/0043"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0036|cit36","unstructured":"EUCTR 2011-001278-24 Efficacy of ranolazine in patients with coronary artery disease (CAD) www.clinicaltrialsregister.eu\/ctr-search\/search?query=Efficacy+of+ranolazine+in+patients+with+coronary+artery+disease+%28CAD%29"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0037|cit37","unstructured":"EUCTR 2012-001584-77 Effect of ranolazine in ischemic patients with indication of staged interventional therapy www.clinicaltrialsregister.eu\/ctr-search\/search?query=A+study+to+investigate+the+effect+of+a+drug+to+treat+angina+pectoris"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0038|cit38","doi-asserted-by":"crossref","unstructured":"Gupta G Varma CM Thakur R Bhardwaj RPS Ahmad M Bansal RK Effect of ranolazine on angina frequency in patients with type 2 DM and chronic stable angina Indian Heart Journal 2014 S11","DOI":"10.1016\/j.ihj.2014.10.031"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0039|cit39","unstructured":"NCT01495520 Ranolazine for improving symptoms of palpitations (RYPPLE) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01495520"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0040|cit40","unstructured":"NCT01558830 Safety of amiodarone and ranolazine together in patients with angina (SARA) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01558830"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0041|cit41","unstructured":"NCT01754259 Effects of ranolazine on coronary flow reserve in symptomatic diabetic patients and CAD (RAND-CFR) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01754259"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0042|cit42","unstructured":"NCT01948310 Effects of ranolazine and exercise on daily physical activity trial (EREDA) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01948310"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0043|cit43","unstructured":"NCT02052011 Ranolazine and microvascular angina by PET in the emergency department (RAMP-ED) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02052011"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0044|cit44","unstructured":"NCT02147067 Microvascular assessment of ranolazine in non-obstructive atherosclerosis (MARINA) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02147067"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0045|cit45","unstructured":"NCT02147834 Effectiveness of ranolazine on reducing chest pain in patients with blockage but no stents (IMWELL3) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02147834"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0046|cit46","unstructured":"NCT02252406 Impact of ranolazine in blood markers in women with angina and metabolic syndrome (IRMA) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02252406"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0047|cit47","unstructured":"NCT02265796 Improvement of subjective well-being by ranolazine among unrevascularized chronic stable coronary artery disease patients (IMWELL) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02265796"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0048|cit48","unstructured":"NCT02423265 Efficacy of ranolazine in patients with chronic total occlusions of coronary arteries https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02423265"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0049|cit49","unstructured":"\u0160ebe\u0161tjen M Rehberjer-Likozar A Vrtovec B Poglajen G Both trimetazidine and ranolazine improve arterial vasoreactivity in patients with ischemic heart disease (Abstract 14057) Circulation 2014 A14057"},{"issue":"25","key":"10.1002\/14651858.CD011747.pub2-BIB0050|cit50","first-page":"e354","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"126","author":"Fihn","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2013.11.070","article-title":"The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials","volume":"113","author":"Banon","year":"2014","journal-title":"American Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD011747.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/2047487314533217","article-title":"Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis","volume":"22","author":"Belsey","year":"2015","journal-title":"European Journal of Preventive Cardiology"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijcard.2014.12.055","article-title":"Ranolazine: Drug overview and possible role in primary microvascular angina management","volume":"181","author":"Cattaneo","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrcardio.2011.129","article-title":"Stable angina pectoris: antianginal therapies and future directions","volume":"9","author":"Chaitman","year":"2011","journal-title":"Nature Reviews. Cardiology"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0055|cit55","unstructured":"Cochrane Community Glossary https:\/\/community-archive.cochrane.org\/glossary"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0056|cit56","first-page":"353","article-title":"Update on ranolazine in the management of angina","volume":"10","author":"Codolosa","year":"2014","journal-title":"Vascular Health and Risk Management"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/1744-1609.12002","article-title":"Chest pain in patients with 'normal angiography': could it be cardiac?","volume":"11","author":"Fiore","year":"2013","journal-title":"International Journal of Evidence-Based Healthcare"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0058|cit58","unstructured":"European Medicines Agency Ranexa (previously Latixa) www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000805\/human_med_001009.jsp&mid=WC0b01ac058001d124"},{"issue":"38","key":"10.1002\/14651858.CD011747.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0060|cit60","unstructured":"US Food Drug Administration Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations www.accessdata.fda.gov\/scripts\/cder\/ob\/default.cfm"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0061|cit61","unstructured":"GRADEpro Guideline Development Tool [software] Available from gradepro.org 2015"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40256-012-0003-2","article-title":"Ranolazine: clinical applications and therapeutic basis","volume":"13","author":"Hawwa","year":"2013","journal-title":"American Journal of Cardiovascular Drugs"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0063|cit63","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD011747.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00003088-200645050-00003","article-title":"Clinical pharmacokinetics of ranolazine","volume":"45","author":"Jerling","year":"2006","journal-title":"Clinical Pharmacokinetics"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tcm.2012.07.014","article-title":"Cardiac syndrome X and microvascular coronary dysfunction","volume":"22","author":"Jones","year":"2012","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"17","key":"10.1002\/14651858.CD011747.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.2165\/0003495-200868170-00006","article-title":"Ranolazine: a review of its use in chronic stable angina pectoris","volume":"68","author":"Keating","year":"2008","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0067|cit67","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD011747.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011168.pub2","article-title":"Implantable defibrillators versus medical therapy for cardiac channelopathies","author":"McNamara","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1186.e1","DOI":"10.1016\/j.ahj.2006.01.004","article-title":"Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial","volume":"151","author":"Morrow","year":"2006 Jun","journal-title":"Am Heart J."},{"key":"10.1002\/14651858.CD011747.pub2-BIB0070|cit70","unstructured":"National Institute for Health and Care Excellence (NICE) Chest pain of recent onset: Assessment and diagnosis (CG95) (Updated 2016) http:\/\/guidance.nice.org.uk\/CG95"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0071|cit71","unstructured":"National Institute for Health and Clinical Excellence Stable angina (CG126) (Updated 2016) http:\/\/guidance.nice.org.uk\/CG126 2011"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0072|cit72","unstructured":"O'Toole L Angina (chronic stable). Systematic review 213 BMJ Clinical Evidence http:\/\/clinicalevidence.bmj.com\/x\/systematic-review\/0213\/overview.html 2008"},{"issue":"12","key":"10.1002\/14651858.CD011747.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMcp1502240","article-title":"Clinical practice. Chronic stable angina","volume":"374","author":"Ohman","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011747.pub2-BIB0074|cit74","first-page":"819","article-title":"Utility of ranolazine in chronic stable angina patients","volume":"4","author":"Patel","year":"2008","journal-title":"Vascular Health and Risk Management"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0075|cit75","unstructured":"Ranexa (product information) Gilead Sciences Inc, Foster City, CA, USA December 2013"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0076|cit76","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"4","key":"10.1002\/14651858.CD011747.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijcard.2013.08.131","article-title":"Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis","volume":"169","author":"Savarese","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011747.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3909\/ricm10S10002","article-title":"Chronic angina: definition, prevalence, and implications for quality of life","volume":"10","author":"Scirica","year":"2009","journal-title":"Reviews in Cardiovascular Medicine"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0079|cit79","unstructured":"Scottish Intercollegiate Guidelines Network Management of stable angina. A national clinical guideline (guideline n\u00b096) http:\/\/www.sign.ac.uk\/guidelines\/fulltext\/96\/"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1590\/S0066-782X2011001500013","article-title":"Quality of life assessment after acute coronary syndrome: systematic review","volume":"97","author":"Silva","year":"2011","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0082|cit82","unstructured":"Stock C Henrot N From OpenSIGLE to OpenGrey: Change and Continuity Grey Journal 2011 93 7"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7861\/clinmedicine.13-1-63","article-title":"Pharmacological treatment of chronic stable angina pectoris","volume":"13","author":"Tarkin","year":"2012","journal-title":"Clinical Medicine"},{"issue":"17","key":"10.1002\/14651858.CD011747.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1517\/14656566.2012.740458","article-title":"Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal","volume":"13","author":"Thadani","year":"2012","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"8","key":"10.1002\/14651858.CD011747.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"e42812","DOI":"10.1371\/journal.pone.0042812","article-title":"Identification of additional trials in prospective trial registers for Cochrane systematic reviews","volume":"7","author":"Enst","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ahj.2013.08.004","article-title":"Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (RIVER-PCI) trial","volume":"166","author":"Weisz","year":"2013","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD011747.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.amjcard.2006.07.052","article-title":"Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials","volume":"99","author":"Wenger","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD011747.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"504915","DOI":"10.1155\/2013\/504915","article-title":"Evaluating symptoms to improve quality of life in patients with chronic stable angina","volume":"2013","author":"Young","year":"2013","journal-title":"Nursing Research and Practice"},{"issue":"6","key":"10.1002\/14651858.CD011747.pub2-BIB0089|cit89","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011747","article-title":"Ranolazine for stable angina pectoris","author":"Salazar","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011747.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:16:23Z","timestamp":1704204983000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011747.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,2,8]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011747.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,8]]}}}